GENERAL7 Sept 2026
Indian pharma market grows 10.7% in August despite 3-month volume low
Indian pharma sales rose 10.7% in August to Rs 23,272 crore. New launches and double-digit growth in acute and chronic therapies lifted value, even as volume growth fell to a three-month low. For pharma businesses and investors, higher prices and a richer product mix are driving revenues, not more consumption. Keep an eye on coming months for a volume recovery.
Key Statutory Highlights
- Indian pharma sales value rose 10.7% in August to Rs 23,272 crore.
- New product introductions and double-digit growth in acute and chronic therapies drove the increase.
- Volume growth slowed to a three-month low during August.
Actionable Advice for Taxpayers / Founders:Track the next monthly volume data to see whether consumer demand catches up with price-led revenue growth.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: